NCT00145652View on ClinicalTrials.gov

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2005

Conditions

AnemiaMultiple MyelomaNon Hodgkin LymphomaChronic Lymphocytic Leukemia

Interventions

DRUG

Neo-Recormon and Venofer

Trial Locations (1)

S 851 86

Michael Hedenus, Sundsvall

All Listed Sponsors

lead

Sundsvall Hospital

OTHER

NCT00145652 - Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. | Biotech Hunter | Biotech Hunter